Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Gonorrhea Figures

 
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the 

STD Data and Statistics page.
 

Figure 12. Gonorrhea — Rates of Reported Cases by Year, United States, 1941–2014Figure 12. Gonorrhea — Rates of Reported Cases by Year, United States, 1941–2014

Figure 13. Gonorrhea — Rates of Reported Cases by Sex, United States, 1994–2014Figure 13. Gonorrhea — Rates of Reported Cases by Sex, United States, 1994–2014

Figure 14. Gonorrhea — Rates of Reported Cases by Region, United States, 2005–2014Figure 14. Gonorrhea — Rates of Reported Cases by Region, United States, 2005–2014

Figure 15. Gonorrhea — Rates of Reported Cases by State, United States and Outlying Areas, 2014Figure 15. Gonorrhea — Rates of Reported Cases by State, United States and Outlying Areas, 2014

Figure 16. Gonorrhea — Rates of Reported Cases by County, United States, 2014Figure 16. Gonorrhea — Rates of Reported Cases by County, United States, 2014

Figure 17. Gonorrhea — Rates of Reported Cases by Age and Sex, United States, 2014Figure 17. Gonorrhea — Rates of Reported Cases by Age and Sex, United States, 2014

Figure 18. Gonorrhea — Rates of Reported Cases Among Women Aged 15–44 Years by Age, United States, 2005–2014Figure 18. Gonorrhea — Rates of Reported Cases Among Women Aged 15–44 Years by Age, United States, 2005–2014

Figure 19. Gonorrhea — Rates of Reported Cases Among Men Aged 15–44 Years by Age, United States, 2005–2014Figure 19. Gonorrhea — Rates of Reported Cases Among Men Aged 15–44 Years by Age, United States, 2005–2014

Figure 20. Gonorrhea — Rates of Reported Cases by Race/Ethnicity, United States, 2010–2014Figure 20. Gonorrhea — Rates of Reported Cases by Race/Ethnicity, United States, 2010–2014

Figure 21. Gonorrhea — Reported Cases by Reporting Source and Sex, United States, 2005–2014Figure 21. Gonorrhea — Reported Cases by Reporting Source and Sex, United States, 2005–2014

Figure 22. Gonorrhea — Percentage of Reported Cases by Sex and Reporting Source, United States, 2014Figure 22. Gonorrhea — Percentage of Reported Cases by Sex and Reporting Source, United States, 2014

Figure 23. Estimated Proportion of MSM, MSW, and Women Among Gonorrhea Cases by Site, STD Surveillance Network (SSuN), 2013Figure 23. Estimated Proportion of MSM, MSW, and Women Among Gonorrhea Cases by Site, STD Surveillance Network (SSuN), 2013

Figure 24. Gonorrhea — Proportion of STD Clinic Patients Testing Positive by Age, Sex, and Sexual Behavior, STD Surveillance Network (SSuN), 2014Figure 24. Gonorrhea — Proportion of STD Clinic Patients Testing Positive by Age, Sex, and Sexual Behavior, STD Surveillance Network (SSuN), 2014

Figure 25. Location of Participating Sentinel Sites and Regional Laboratories, Gonoccoccal Isolate Surveillance Project (GISP), United States, 2014Figure 25. Location of Participating Sentinel Sites and Regional Laboratories, Gonoccoccal Isolate Surveillance Project (GISP), United States, 2014

Figure 26. Neisseria gonorrhoeae — Percentage of Isolates with Elevated Ceftriaxone Minimum Inhibitory Concentrations (MICs) (≥0.125 μg/ml), Gonococcal Isolate Surveillance Project (GISP), 2006–2014Figure 26. Neisseria gonorrhoeae — Percentage of Isolates with Elevated Ceftriaxone Minimum Inhibitory Concentrations (MICs) (≥0.125 μg/ml), Gonococcal Isolate Surveillance Project (GISP), 2006–2014

Figure 27. Neisseria gonorrhoeae — Percentage of Isolates with Elevated Cefixime Minimum Inhibitory Concentrations (MICs) (≥0.25 μg/ml), Gonococcal Isolate Surveillance Project (GISP), 2006–2014 Figure 27. Neisseria gonorrhoeae — Percentage of Isolates with Elevated Cefixime Minimum Inhibitory Concentrations (MICs) (≥0.25 μg/ml), Gonococcal Isolate Surveillance Project (GISP), 2006–2014 

Figure 28. Neisseria gonorrhoeae — Distribution of Azithromycin Minimum Inhibitory Concentrations (MICs), Gonococcal Isolate Surveillance Project (GISP), 2010–2014Figure 28. Neisseria gonorrhoeae — Distribution of Azithromycin Minimum Inhibitory Concentrations (MICs), Gonococcal Isolate Surveillance Project (GISP), 2010–2014

Figure 29. Neisseria gonorrhoeae — Percentage of Isolates with Penicillin, Tetracycline, and/or Ciprofloxacin Resistance, Gonococcal Isolate Surveillance Project (GISP), 2014Figure 29. Neisseria gonorrhoeae — Percentage of Isolates with Penicillin, Tetracycline, and/or Ciprofloxacin Resistance, Gonococcal Isolate Surveillance Project (GISP), 2014

Figure 30. Primary Antimicrobial Drugs Used to Treat Gonorrhea Among Participants, Gonococcal Isolate Surveillance Project (GISP), 1988–2014Figure 30. Primary Antimicrobial Drugs Used to Treat Gonorrhea Among Participants, Gonococcal Isolate Surveillance Project (GISP), 1988–2014


Next

Top